Uncontrolled/hyperactivated PI3K/AKT/mTOR signaling leads to dysregulated protein synthesis, which contributes to carcinogenesis and cancer progression (Golob-Schwarzl et al. 2017; Jackson et al. 2010; Spilka et al. 2013; Engelman 2009; Liu et al. 2009). Here, MTOR is linked to cancer.